![Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD | npj Primary Care Respiratory Medicine Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-021-00255-7/MediaObjects/41533_2021_255_Fig1_HTML.png)
Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD | npj Primary Care Respiratory Medicine
![Full article: Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease* Full article: Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*](https://www.tandfonline.com/cms/asset/4cc5f998-b161-41ab-b08d-2b3746676dd1/icop_a_1618256_f0001_b.jpg)
Full article: Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*
![Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/85/2_suppl_1/S19/F1.large.jpg)